Journal
JOURNAL OF BLOOD MEDICINE
Volume 5, Issue -, Pages 59-68Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JBM.S39220
Keywords
platelet; bleeding; antithrombotic; hemostasis; glycoprotein; vessel; thrombosis
Categories
Funding
- National Health and Medical Research Council of Australia
Ask authors/readers for more resources
While platelet activation is essential to maintain blood vessel patency and minimize loss of blood upon injury, untimely or excessive activity can lead to unwanted platelet activation and aggregation. Resultant thrombosis has the potential to block blood vessels, causing myocardial infarction or stroke. To tackle this major cause of mortality, clinical therapies that target platelet responsiveness (antiplatelet therapy) can successfully reduce cardiovascular events, especially in people at higher risk; however, all current antiplatelet therapies carry an increased probability of bleeding. This review will evaluate new and emerging targets for antithrombotics, focusing particularly on platelet glycoprotein VI, as blockade or depletion of this platelet-specific receptor conveys benefits in experimental models of thrombosis and thromboinflammation without causing major bleeding complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available